FAcilitates Chromatin Transcription (FACT) is a complex of SSRP1 and SPT16 that is involved in chromatin remodeling during transcription, replication, and DNA repair. FACT has been mostly studied in cell-free or single cell model systems because general FACT knockout (KO) is embryonically lethal (E3.5). FACT levels are limited to the early stages of development and stem cell niches of adult tissues. FACT is upregulated in poorly differentiated aggressive tumors. Importantly, FACT inhibition (RNAi) is lethal for tumors but not normal cells, making FACT a lucrative target for anticancer therapy. To develop a better understanding of FACT function in the context of the mammalian organism under normal physiological conditions and in disease, we aimed to generate a conditional FACT KO mouse model. Because SPT16 stability is dependent on the SSRP1-SPT16 association and the presence of SSRP1 mRNA, we targeted the Ssrp1 gene using a CreER T2 -LoxP approach to generate the FACT KO model. Here, we highlight the limitations of the CreER T2 -LoxP (Rosa26) system that we encountered during the generation of this model. In vitro studies showed an inefficient excision rate of ectopically expressed CreER T2 (retroviral CreER T2
T2
-LoxP approach to generate the FACT KO model. Here, we highlight the limitations of the CreER T2 -LoxP (Rosa26) system that we encountered during the generation of this model. In vitro studies showed an inefficient excision rate of ectopically expressed CreER T2 (retroviral CreER T2 ) in fibroblasts with homozygous floxed Ssrp1. In vitro and in vivo studies showed that the excision efficiency could only be increased with germline expression of two alleles of Rosa26CreER -LoxP system may be sufficient for studies involving the deletion of genes that interfere with cell growth or viability due to the positive selection of the phenotype. However, it may not be sufficient for studies that involve the deletion of genes supporting growth, or those crucial for development. Although CreER T2 -LoxP is broadly used, it has limitations that have not been widely discussed. This paper aims to encourage such discussions. a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
Introduction
Facilitates Chromatin Transcription (FACT), a heterodimeric complex of SSRP1 and SPT16, is a histone chaperone that is involved in chromatin remodeling through its binding to histone oligomers and modulation of nucleosome stability in the vicinity of ongoing RNA and DNA synthesis [1] . FACT has been implicated in multiple processes, including transcription, replication, recombination, and repair [1] . Mutations in the FACT subunits can affect the viability of yeast, and general Ssrp1 knockout (KO) is lethal at 3.5 days post-copulation (dpc) [2] . However, expression of FACT goes down in human and mouse tissues after early embryogenesis. Later, it is detected almost exclusively in the stem cell niches of several organs [3] . FACT is overexpressed in multiple types of aggressive undifferentiated human tumors with poor prognosis [3, 4] . Furthermore, inhibition of FACT (RNAi-mediated) is tolerable for normal cells in vitro but causes growth arrest and death of tumor cells, including cancer stem cells [4] [5] [6] [7] . These data suggest that targeting FACT presents an opportunity for the development of a novel anticancer therapeutic approach. However, FACT has primarily been studied in single cell models in vitro or in cell-free systems [1, 4] . Thus, to understand the role of FACT in postembryonic development, tumorigenesis, and tumor progression, we attempted to generate an inducible conditional FACT KO mouse model using the site-specific recombinase CreER T2 .
Since both SSRP1 and SPT16 are stable only when bound to each other and RNAi-mediated repression of SSRP1 expression effectively eliminates both subunits [4, 8] , we targeted FACT by deleting part of the Ssrp1 gene. Bacteriophage-derived Cre is one of the most widely used site-specific recombinases for gene targeting. Cre recognizes a 34 bp nucleotide sequence known as the LoxP site [9] . To achieve conditional KO, the LoxP sequences are inserted into the intronic regions both upstream and downstream of the critical exons to flank/flox (fl) the region of interest of the endogenous gene [10] . Cre recognizes and recombines these sequences resulting in the deletion of a part of the whole gene, which subsequently inactivates gene function [9, 11] .
Temporal control of Cre activity can be achieved by using Cre fusion proteins with mutant ligand binding domains of the estrogen receptor (Cre-ER T ) that can be activated upon tamoxifen binding [9] . The G521R mutant of the ER ligand binding domain (ER T ) compromises the ER binding of its natural ligand (17-β-estradiol) but promotes the binding of the synthetic ligand tamoxifen or 4-hydroxytamoxifen (4-OHT) [12, 13] . In the absence of tamoxifen, the Cre-ER T fusion protein is located in the cytoplasm and binds to the heat-shock protein Hsp90. In the presence of tamoxifen, Hsp90 is displaced from Cre-ER T , allowing the Cre-ER T fusion protein to move into the nucleus by exposing its nuclear localization signal [14] [15] [16] [17] [18] [19] [20] . This control over Cre-mediated recombination provides more flexibility for conditional mutagenesis in mice, especially for genes that are essential for early development, such as Ssrp1. Cre-ER T has a preference for tamoxifen over estrogen but the selectivity is not sufficient [21] . Therefore, the ER ligand binding domain was further mutated to improve the specificity, resulting in newer versions of Cre-ER T (e.g., MER-Cre-MER and Cre-ER
T2
). Cre-ER T2 carries three mutations in the ER ligand binding domain (G400V/M543A/L544A) and has a ten-fold greater sensitivity to 4-OHT compared to Cre-ER T [17] . Since its development, numerous studies have been conducted using Cre-ER T2 . Despite its popularity, we and others have observed a number of limitations of the Cre-ER T2 -LoxP system, including low efficiency of recombination and "leakiness" in expression [21] [22] [23] [24] [25] [26] . Only a few studies have reported the excision efficiency of this system, which varies from 30 to 80% [21] [22] [23] [24] [25] [26] . The low excision rate may potentially be due to the size of the DNA between the two LoxP sites, mosaic expression of CreER
, and incomplete excision of the floxed loci. However, these limitations have not been widely discussed. The low efficiency of excision may be sufficient for studies involving deletion of genes that negatively affect cell growth or viability because of the positive selection of the cells in which recombination has taken place. However, many studies require a higher rate of excision to fully understand the function of a gene (e.g., studies involving the deletion of genes that may have a positive effect on cell growth) because cells with recombination may be easily overgrown by cells without recombination. In our efforts to develop an inducible conditional Ssrp1 KO mouse model using the CreER T2 -LoxP system, we encountered multiple problems due to its low efficiency and leakiness. Here, we present these limitations and ways to resolve them.
Materials and methods

Reagents and plasmids
Knockout ™ DMEM medium (catalog no. 10829018 ThermoFisher) supplemented with 15% fetal bovine serum (FBS) (catalog no.10438026 ThermoFisher) was used for culturing embryonic stem (ES) cells. F-12K medium (Ham's F-12K nutrient mix Kaighn's modification medium;, catalog no. 21127022 ThermoFisher) supplemented with 1% AntibioticAntimycotic (AA) solution (catalog no. 15240-062 ThermoFisher) and 10% FBS was used for culturing primary fibroblasts. DMEM medium (catalog no. 11995073 GIBCO Life Technologies) supplemented with 10% FBS and 1% penicillin-streptomycin (catalog no. 15140-122 ThermoFisher) was used for culturing immortalized and transformed mouse fibroblasts.
Tamoxifen (catalog no. T5648), 4-OHT (catalog no. H7904), Trichostatin A (catalog no. 58880-19-6), and polybrene (catalog no. H9268) were purchased from Sigma-Aldrich. Collagenase A (catalog no. 10103578001) was purchased from Roche. Hoechst 33342 was purchased from ThermoFisher (catalog no. H3570).
The following antibodies were used for immunoblotting and immunofluorescence: mouse monoclonal anti-p53 (catalog no. PAb421MilliporeSigma), mouse monoclonal anti-SSRP1 (10D1, catalog no. 609702, BioLegend, Inc), mouse monoclonal anti-SPT16 (8D2, catalog no. 607002, BioLegend, Inc), rabbit polyclonal H-RAS C-20 (sc-520, Santa Cruz Biotechnology), rabbit monoclonal anti-Cre recombinase (D7L7L XP 
Transfection and transduction
Lentiviruses and retroviruses were generated in the 293T cell line (Clontech) transfected with the appropriate expression vector along with packaging plasmids using PolyJet™ In Vitro DNA Transfection Reagent (catalog no. SL100688 SignaGen 1 Laboratories) according to the manufacturer's instructions. Virus-containing media from 293T cells were collected 48 h and 72 h later, syringe-filtered through a 0.45 μm filter, and transferred to target cells in the presence of polybrene (10 μg/ml). ). ES cell electroporation. ES cell electroporation was performed by the Gene Targeting and Transgenic Shared Resource at Roswell Park Comprehensive Cancer Center. Briefly, SSRP1 mutant clones were grown in complete ES cell medium on a feeder layer in a 100 mm dish. On the day of electroporation, the ES cells were trypsinized to prepare a single cell suspension. A circular plasmid (11 μg) containing a puromycin resistance cassette was electroporated into the cells. Puromycin selection (0.6 μg/mL) was carried out for 3 to 4 days beginning the day after electroporation. Colonies were picked and transferred to individual wells of a 24-well plate one week after electroporation. ES cell clones were tripsinized, and protein and DNA were isolated to assess the excision of FRT sites.
Animal housing and maintenance
Screening of ES clones for homologous recombination using Southern blotting. DNA was isolated from the ES cells using the Wizard 1 Genomic DNA Purification Kit (Promega, catalog no. A1120). Southern blotting was performed as previously described [27] . Genomic DNA was digested with either BsrG1 or Ace1/Nde1. DNA was separated on a 0.8% agarose gel, and transferred to a nylon membrane for Southern blotting. The 5' hybridization probe (included region size: 8821-9200) was generated by PCR using the following primers: forward primer CGCTTGATGCACTTTTGCTA; reverse primer CAGGACGTTGATGGAAGACA (product size: 347). The 3' hybridization probe (included region size: 28590-30625) was generated by PCR using the following primers: forward primer GCATTGGTTTTCACCCTTGT; reverse primer CCCCACGTGGATAAATTCTG and a product size: 417 Genotyping. Genotyping was done using PCR. Tail tips (1 to 2 mm) were dissolved in 200 μL DirectPCR Lysis Reagent (catalog no. 102-T Viagen) containing 0.2 mg/mL Proteinase K (catalog no. AM2546 Ambion) and incubated overnight at 55˚C. The crude lysates were incubated at 85˚C for 45 min to inactivate Proteinase K and then centrifuged at 10,000 rpm for 1 min to collect the crude DNA sample in the supernatant. The an approximately 2 cm piece of the tail tip was collected. The samples were washed in sterile 1xPBS containing 1% AA. The tail tips were minced into small pieces using a pair of scissors. F-12K medium containing 1% AA and 2mg/ml Collagenase A (10 ml) was added to the samples, which were incubated for 2 h at 37˚C with shaking. The samples were centrifuged at 1200 rpm for 10 min at room temperature. The pellet was resuspended in 7 mL F-12K medium containing 10% FBS and 1% AA and placed in a 100 mm plate (catalog no. 40-229690, Krackeler). The plates were kept in a sterile humidified tissue culture incubator at 37˚C and 5% CO 2 for 4 to 5 days to allow cells to adhere to the plate. To generate immortalized fibroblasts, primary fibroblasts were infected with genetic suppressor element 56 (GSE56) virus and subsequently selected with 500 μg/ml neomycin (G418 Sulfate). Post-selection, the cells were maintained in DMEM medium supplemented with 10% FBS and 1% penicillin-streptomycin.
Generation of primary, immortalized, and transformed cells
For the generation of transformed fibroblasts, the immortalized fibroblasts were infected with oncogenic H-RAS V-12 virus and selected with bleomycin (30 ug/ml) for approximately one week.
Excision of Ssrp1 (in vitro and in vivo)
For the excision of Ssrp1 in vitro, primary, immortalized, or transformed cells (1x10 6 ) were plated in 150 mm plates. The cells were treated with 2 μM 4-OHT for 96 h (primary cells) or 120 h (immortalized and transformed cells). The medium was replaced every 48 h with fresh 2 μM 4-OHT containing medium. The excision of Ssrp1 was confirmed at both the DNA and protein level. (1 μg/mL) for 10 min. Images were acquired using a Zeiss Axio Observer A1 inverted microscope with N-Achroplan 100x/1.25 oil lens, Zeiss MRC5 camera, and AxioVision Rel.4.8 software. Image analysis and quantification were performed using ImageJ software. Each image was divided into four quadrants, and ten cells in each quadrant were analyzed to determine the corrected total cell fluorescence (CTCF) using the following equation: CTCF = integrated density-(area of the selected cell x the mean fluorescence of background readings).
Methylene blue staining
Primary (1x10 6 ) or immortalized or transformed (5x10 5 ) fibroblasts were seeded in duplicate in a 6-well plate and allowed to grow to confluency (~3 to 4 days). Cells were fixed and stained with 0.5% methylene blue staining solution (1 ml per well) in 50% methanol (, catalog no. M4159 MilliporeSigma) for 10 min at room temperature with shaking. The stained cells were washed with water, and the plates were air dried.
Expression of the excised gene was determined using F1 and R2 (F1:R2). qPCR was performed using Applied Biosystems Power SYBR 1 Green PCR Master Mix (, catalog no. 4367659 ThermoFisher) according to the manufacturer's instructions using the default parameters of the 7900HT sequence detection system (ABI PRISM; Applied Biosystems).
To compare gene expression between samples, the threshold cycle (CT) value was normalized using the mean CT for the reference gene (GAPDH) to obtain the ΔCT. To quantify the excised allele (F1:R2) and mutant allele (F1:R3) in 4-OHT/tamoxifen-treated samples, the ΔΔCT was calculated using the equation ΔCT F1:R2 -ΔCT F1:R3. The final data were expressed as the fold difference defined as 2 -(ΔCT F1:R2 -ΔCT F1:R3) .
β-Galactosidase (lacZ) activity assay
Lungs, testis, colon, and pancreas were harvested from Ssrp1 +/+ and Ssrp1 LacZ Neo fl /+ mice and washed in 1x PBS on ice. Tissues were fixed (1x PBS+ 0.2% glutaraldehyde + 2% formaldehyde) on ice for 45 min. Tissues were washed three times (15 min each) in wash buffer (2 mM MgCl 2 , 0.01% sodium deoxycholate, and 0.02% nonidet P-40 in 1x PBS) and then incubated with staining solution (1mg/ml X-gal (in dimethylformaldehyde), 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 2 mM MgCl 2 , 0.01% sodium deoxycholate and 0.02% nonidet P-40 in 1x PBS) for 3 h at 37˚C in the dark. After staining, Tissues were washed three times with 1x PBS for 15 min each at room temperature.
Statistical analysis
The unpaired t-test (Mann-Whitney test) was used for comparisons of quantitative data from the control and treated groups. Analyses were conducted using GraphPad Prism 7.03. All pvalues are two-sided. Previously, we showed that FACT stability is dependent on the dimerization of its two subunits (i.e., SPT16 and SSRP1) [8] . Furthermore, SPT16 is only stable when SSRP1 mRNA is present in the complex [8] . Therefore, a targeting vector that allowed for conditional KO of Ssrp1 was used to generate a conditional FACT KO mouse model. The EUCOMM targeting vector consisted of the complete Ssrp1 gene with two LoxP sites flanking exons 4 to 9 of Ssrp1 and a synthetic cassette. The synthetic cassette consisted of a promoter-less LacZ gene and neomycinresistance gene (Neo r ) under the control of the β-actin promoter. A third LoxP site was located upstream of the β-actin promoter. This synthetic cassette, which was flanked by two FRT sites, was within the intronic region between exons 3 and 4 of Ssrp1 (Fig 1A) . Similar to the CreLoxP system, the Flp-FRT site-specific recombinase system uses FRT sites that are recognized and recombined by Flp recombinase [28] . The targeting vector was electroporated into G4 (B6.129s) mouse ES cells. Following selection with G418, Southern blot-based screening for the 3' and 5' recombination arms was used to identify clones containing the homologous recombination of the mutant (Ssrp1
Results
I. Generation of a mouse model with conditional deletion of
Neo LacZ fl
) Ssrp1 allele in place of the endogenous wild-type allele (Ssrp1 + ) (Fig 1C) . Chimeras were generated and subsequently bred with wild-type mice (Ssrp1
) to obtain an F1 generation of heterozygous (Ssrp1 Neo LacZ fl/+ ) mice. Their genotypes were determined by PCR (Fig 1D) .
Ssrp1 is not expressed ubiquitously [3] in adult mice. LacZ did not have its own promoter and could be expressed under the control of the endogenous Ssrp1 promoter. β-galactosidase staining was performed to compare the expression of mutant and wild-type alleles. Positive staining was observed in tissues from heterozygous mice that expressed SSRP1, including testes (high FACT expression), colon (moderate FACT expression), and pancreas (weak FACT expression). Staining was absent in tissues that do not express SSRP1 (e.g., lung). Thus, the Ssrp1 Neo Lacz fl allele had a similar expression pattern to that of the wild-type Ssrp1 + allele. Tissues from wild-type mice were negative for LacZ staining (Fig 1E) . (Fig 2A) . We hypothesized that the strong β-actin promoter used for Neo expression might be interfering with Ssrp1 expression. However, we later learned that the targeting vector provided by the EUCOMM was predicted to generate a null allele through splicing to the lacZ trapping element contained in the synthetic cassette. Unfortunately, this characteristic of the synthetic cassette was not explicitly explained by EUCOMM and has only been discussed in one publication [29] . To generate homozygous floxed Ssrp1 mice, we had to remove the synthetic cassette using Flp-mediated FRT recombination. Ssrp1
Neo LacZ fl /+ mice were crossed with mice expressing Flp recombinase (Flpe). From this cross, only~28% of the progeny had the synthetic cassette excised based on 14 pups from two litters (Fig 2B) , which suggested that the rate of excision at the FRT sites by Flpe was low. To overcome this problem, we obtained mice expressing FlpO recombinase. According to the literature, FlpO has a higher recombination efficiency compared to Flpe [30, 31] . Use of the FlpO recombinase resulted in~43% of the progeny undergoing recombination based on 14 pups from two separate litters (Fig 2C) . To determine if the excision efficiency could be improved in vitro, ES cells were electroporated with either Flpe or FlpO plasmid and tested for the excision of the synthetic cassette ) were now comparable to that of Ssrp1 +/+ mice (Fig 2D) . The fine print of CreER , and Ssrp1 fl/fl mice. We previously observed very low FACT levels in primary non-tumor cells. However, FACT levels were increased upon oncogene-induced transformation of the primary cells [32] . Therefore, to establish in vitro FACT-positive cells, we immortalized primary tail fibroblasts using the dominant negative p53 genetic suppressor element 56 (GSE56 [32] ) and then transformed the immortalized cells using H-Ras V12 oncogene. As expected, immortalized and transformed cells expressed higher levels of the FACT subunits (Fig 3A) . Immortalized and transformed cells were infected with retroviral CreER T2 recombinase (MSCV CreER T2- with puromycin selection marker [33] ) followed by puromycin selection. After selection, cells were treated with 4-OHT (2 μM), an active metabolite of tamoxifen. SSRP1 protein levels were slightly reduced at some time points after the start of treatment with 4-OHT (48 to 120 h), but no clear time-dependence was observed (Fig 3B, 3C and 3D ). PCR analysis confirmed excision of the critical exons of Ssrp1 (Ssrp1 Δ ) following treatment with 4-OHT. However, the presence of an unrecombined Ssrp1 fl allele was also detected (Fig 3E) . These data suggested that the excision was happening only in a fraction of cells in the population or only one Ssrp1 fl allele was excised. These results may be due, in part, to the heterogeneity among cells in the population with respect to Cre-recombinase expression levels.
To test this hypothesis, single cell clones of transformed Ssrp1 fl/fl MSCV CreER fibroblasts were generated by limiting dilution. Cloned cells were subjected to 4-OHT treatment, and SSRP1 immunofluorescence was performed to identify the clones with complete excision of Ssrp1. Variable excision was observed within each clone, and no clones demonstrated uniform excision in all cells in response to 4-OHT (Fig 4 and S2 Fig) . were treated with a range of 4-OHT concentrations in the absence or presence of TSA (100 ng/ ml) for 48 h. SSRP1 protein levels were reduced following 4-OHT treatment in the presence of TSA. However, a reduction in SSRP1 protein levels was also observed with TSA alone ( Fig  5A) . Genomic DNA PCR showed no improvement in the excision efficiency, suggesting that the opening of chromatin was not sufficient to improve the recombination efficiency of ectopically expressed CreER T2 (Fig 5B) .
Another possibility for the low excision efficiency was low Cre-ER T2 expression. To test this hypothesis, we evaluated the cytoplasmic and nuclear distribution of CreER h. Ssrp1 excision in these cells was assessed using PCR ( Fig 5C) . The results showed the presence of a recombined Ssrp1 allele in both 4-OHT-treated and untreated samples, which suggested that germline CreER T2 is leaky. Moreover, the Ssrp1 fl allele was still observed in 4-OHTtreated cells, which suggested that like retroviral CreER following treatment with 4-OHT and TSA increased compared to the ectopically expressed CreER T2 as seen by the decrease in the Ssrp1 fl band in genomic DNA analysis (Fig 5E) . In addition, the absence of SSRP1 protein upon TSA treatment showed that the opening of the chromatin enhanced the excision rate of endogenously expressed CreER
T2
. However, SSRP1 was absent following TSA treatment even in the absence of 4-OHT. These data suggest that either CreER T2+/-is leaky or the inhibition of HDAC causes a reduction of FACT subunit protein levels or both (Fig 5D) . The fine print of CreER T2 -LoxP system
Since the CRE-mediated recombination efficiency was low when only one allele of CreER T2 was present, we tested whether the presence of two alleles of CreER T2 would be more efficient.
We generated mice homozygous for both floxed Ssrp1 and CreER T2 (Ssrp1
fl/fl
CreER T2+/+ ), and then generated primary, immortalized, and transformed cells as described above. 4-OHT treatment significantly reduced SSRP1 levels in all cell types (Fig 6A) . PCR analysis of genomic DNA also confirmed excision of the critical exons of Ssrp1 and absence of the mutant allele of SSRP1 upon treatment with 4-OHT (Fig 6B) . Thus, expression of CreER T2 from two alleles resulted in a much more efficient recombination, which in turn was more efficient than recombination from ectopically expressed CreER T2 (MSCV CreER T2 ) (Fig 6C) . CreER T2+/-mice ( Fig 7B) . Because of the small sample size, the differences did not reach statistical significance. However, these observations potentially indicate that, like in vitro, two alleles of Rosa26 CreER T2 are required to achieve complete excision of Ssrp1 in mice.
IV. Excision of
Discussion
CreER T2 -mediated gene inactivation is a powerful tool to study a gene of interest with temporal and spatial control. However, to fully understand the function of a gene, it is important that the Cre recombination be efficient and complete. Here, we report the limitations of the CreER T2 system encountered while generating the Ssrp1 KO mouse model. The results of this study highlight the inefficiencies of this system and provide insights on how to increase the recombination efficiency. We understand that each case of genetic engineering potentially has specific limitations, which may result from specific gene or genomic features. Thus, the experience that we report here may only be fully applicable to Ssrp1. Nevertheless, we believe it is The fine print of CreER T2 -LoxP system pertinent to disclose such observations to develop a better understanding of the most widely used system for genetic manipulation.
The (Fig 5A and 5B) .
Expression of a single germline copy of Rosa 26 CreER T2 (CreER T2+/-) also resulted in incomplete excision of Ssrp1. We found that CreER T2+/-was leaky (in vitro) as both Ssrp1 Δ and Ssrp1 fl were present in the absence of 4-OHT treatment (Fig 5C) . Although partial excision of Ssrp1 using ectopically expressed CreER T2 was not due to inaccessibility of Cre to the chroma- (Fig 5D and  5E ). We also saw the presence of Ssrp1 Δ in cells treated with TSA alone (i.e., no 4-OHT treatment), confirming that CreER T2+/-was leaky. FACT expression is critical for the survival of transformed cells and, to some extent, immortalized cells [4] . Therefore, cells expressing CreER T2 might have undergone complete excision of Ssrp1 in the absence of 4-OHT but did not survive. Only cells that had incomplete excision of Ssrp1 survived. Thus, we could see both Ssrp1 Δ and Ssrp1 fl bands in our assay and the presence of SSRP1 in these cells. Therefore, expression of a single copy of Rosa 26 CreER T2 allele was inefficient in yielding homozygous excision of Ssrp1. However, we found that two copies of Rosa26 CreER T2 expressed in the germline led to complete excision of Ssrp1 both in vitro and in in vivo. Hence, to achieve homozygous excision of Ssrp1, two endogenously expressed alleles of Rosa26 CreER T2 are required. Furthermore, determination of excision frequency is necessary for correct assessment of results. The CreER T2 -LoxP system was developed in the late 1990s to early 2000s. It has led to many novel and interesting discoveries, and this system prevails even today in the field of gene targeting. With the development of CRISPR technology, the use of Cre-LoxP has been reduced. However, the use of CreER T2 -LoxP remains constant as a frequently used recombinase system to generate a KO mouse model with temporal and spatial control. Our study describes important factors to consider when employing this system to generate a conditional KO mouse model, particularly of a gene that may play a necessary role in tumor promotion. Our results may not be applicable to studies involving inducible KO of a tumor suppressor gene or the knock-in of a gene. 
